Invitation to presentation of Bactiguard’s year end report for 2014 on February 19

Bactiguard Holding AB publishes the year end report for 2014 on Thursday 19
November at 08:00 CET
In connection with this, a conference call for analysts and media will be held
at 10:00 CEO on February 19. CEO Johan Rugfelt and CFO Fredrik Järrsten will
present the report and answer questions.

The year end report will be available at Bactiguard’s website www.bactiguard.com
from 08:00 CET the same day.

To participate in the conference call, please dial +46 8 566 426 66

For further information, please contact:
Cecilia Edström, Acting Director of Sales, Marketing and Communications
mobile: +46 722 262 328; e-mail: cecilia.edstrom@bactiguard.com

For questions about participation in the conference call, please contact:
Susann Remnert, Communication Manager, mobile: +46 709 195 342
e-mail: susann.remnert@bactiguard.se
About Bactiguard

Bactiguard is a Swedish medtech company with a business concept of preventing
healthcare-related infections, reducing the use of antibiotics and saving lives
by developing and supplying infection prevention solutions for the healthcare
industry. The company’s patented coating prevents healthcare-associated
infections by reducing bacterial adhesion and growth on medical devices.
Bactiguard®-coated urinary catheters are market leading in the US and Japan, and
in recent years the company has developed its own product portfolio of coated
catheters for the urinary and respiratory tract and the blood stream. Bactiguard
is currently in a strong expansion phase, focused on new markets in the EU,
Middle East, Asia and South America. The company reported sales of approximately
SEK 130 million in 2013 and has 60 employees, headquarters in Stockholm and
production facilities in Sweden and Malaysia. The Bactiguard share is listed on
Nasdaq Stockholm. Read more at: www.bactiguard.se